Susquehanna International Group, LLP Enveric Biosciences, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$8.8 - $16.2 $1.55 Million - $2.86 Million
-176,363 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$12.5 - $52.0 $1.95 Million - $8.1 Million
155,758 Added 755.92%
176,363 $58,000
Q4 2021

Feb 14, 2022
BUY
$46.5 - $104.0 $958,132 - $2.14 Million
20,605 New
20,605 $19,000

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $644K
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email